Biocorrx (OTCMKTS:BICX – Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02, Zacks reports. The business had revenue of ($0.04) million during the quarter, compared to analyst estimates of $0.25 million.
Biocorrx Stock Up 7.7%
OTCMKTS BICX opened at $0.23 on Wednesday. Biocorrx has a 52 week low of $0.15 and a 52 week high of $1.28. The business’s fifty day simple moving average is $0.22 and its 200-day simple moving average is $0.30. The firm has a market cap of $6.91 million, a PE ratio of -5.64 and a beta of 0.07.
About Biocorrx
Read More
- Five stocks we like better than Biocorrx
- Disney Has the Magic Touch: Dividend Growth and Buybacks Could Fuel a Breakout
- NVIDIA’s Turbulence Could Have Ripple Effects Across Quantum Computing
- Banking on AI: Can Upstart’s New Bank Plan Turn Its Stock Around?
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
